Robotics & Automation was Novanta’s largest region in fiscal 2025, bringing in $637.15M of $1.96B (32%).
| Contract with customer end market. | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Robotics & Automation | $616.47M | $546.94M | $576.63M | $637.15M | ||||||||||
| Medical Solutions | — | — | — | — | ||||||||||
| Precision Medicine & Manufacturing | — | — | — | — | ||||||||||
| Advanced Surgery | $365.59M | $407.20M | $417.51M | $484.89M | ||||||||||
| Precision Manufacturing | $451.71M | $451.50M | $404.61M | $364.52M | ||||||||||
| Photonics | — | — | — | — | ||||||||||
| Precision Medicine | $288.04M | $357.68M | $499.74M | $474.64M | ||||||||||
| Vision | — | — | — | — | ||||||||||
| Laser Products | — | — | — | — | ||||||||||
| Precision Motion | — | — | — | — | ||||||||||
| Vision Technologies | — | — | — | — | ||||||||||
| Medical Technologies | — | — | — | — | ||||||||||
| Total | $1.72B | $1.76B | $1.90B | $1.96B |
Novanta brought in $1.96B from its four regions in fiscal 2025, the year ended December 31, 2025. That was up 3.3% from $1.90B in fiscal 2024. Robotics & Automation was the largest at $637.15M (32.5%), ahead of Advanced Surgery at $484.89M (24.7%) and Precision Medicine at $474.64M (24.2%). The remaining region, Precision Manufacturing, brought in $364.52M.
Compared with fiscal 2024, Advanced Surgery grew fastest, up 16.1% to $484.89M, while Precision Manufacturing fell the most, down 9.9% to $364.52M. From fiscal 2022 to 2025, combined revenue from these regions grew from $1.72B to $1.96B, a compound annual growth rate of 4.4%. Robotics & Automation's share of the total fell from 35.8% to 32.5%.
United States was Novanta’s largest region in fiscal 2025, bringing in $1.04B of $1.96B (53%).
| Geography | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $744.69M | $836.53M | $974.23M | $1.04B | ||||||||||
| Rest Of Europe | $275.61M | $274.05M | $257.74M | $274.81M | ||||||||||
| Germany | $267.46M | $256.46M | $246.49M | $229.29M | ||||||||||
| Rest Of Asia-Pacific | $203.19M | $210.70M | $214.11M | $194.07M | ||||||||||
| China | $194.36M | $146.89M | $169.12M | $186.40M | ||||||||||
| Other Countries | $36.51M | $38.69M | $36.80M | $38.61M | ||||||||||
| Total | $1.72B | $1.76B | $1.90B | $1.96B |
Novanta brought in $1.96B from its six regions in fiscal 2025, the year ended December 31, 2025. That was up 3.3% from $1.90B in fiscal 2024. United States was the largest at $1.04B (52.9%), ahead of Rest Of Europe at $274.81M (14.0%) and Germany at $229.29M (11.7%). The other three regions brought in $419.08M combined.
Compared with fiscal 2024, China grew fastest, up 10.2% to $186.40M, while Rest Of Asia-Pacific fell the most, down 9.4% to $194.07M. From fiscal 2022 to 2025, combined revenue from these regions grew from $1.72B to $1.96B, a compound annual growth rate of 4.4%. United States' share of the total rose from 43.3% to 52.9%.
Automation Enabling Technologies was Novanta’s largest region in fiscal 2025, bringing in $1.00B of $1.49B (67%).
| Contract With Customer End Market | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Automation Enabling Technologies | $1.07B | $998.44M | $981.24M | $1.00B |
| Medical Solutions | $365.59M | $407.20M | $499.74M | $484.89M |
| Total | $1.43B | $1.41B | $1.48B | $1.49B |
Novanta brought in $1.49B from its two regions in fiscal 2025, the year ended December 31, 2025. That is less than the $1.96B it reports by contract with customer end market., so these regions do not cover all of its revenue. Automation Enabling Technologies was the largest at $1.00B (67.4%), ahead of Medical Solutions at $484.89M (32.6%).
Compared with fiscal 2024, Automation Enabling Technologies grew 2.1% to $1.00B, while Medical Solutions fell 3.0% to $484.89M.
Novanta (NOVT) reports its revenue by contract with customer end market., by geography and by contract with customer end market. In fiscal 2025, Robotics & Automation was its largest region, bringing in $637.15M (32.5% of the total), followed by Advanced Surgery at $484.89M (24.7%).
Robotics & Automation was Novanta's largest region in fiscal 2025, bringing in $637.15M, or 32.5% of the $1.96B total across its four regions.
Among Novanta's regions that make up at least 2% of revenue, Advanced Surgery grew fastest in fiscal 2025, up 16.1% from $417.51M to $484.89M.
Every figure comes from Novanta's annual financial filings, as reported. Each line keeps the name Novanta gives it, and years follow its fiscal calendar.
Novanta's revenue by contract with customer end market. goes back to fiscal 2012, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.